FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns | Fox Lake Towing and Recovery

Home
Towing

FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns

by Melly Alazraki on Feb.01, 2011, under Towing

FDA Rejects Orexigen's New Diet Drug Contrave Over Heart Concerns

In a surprise move Tuesday, the FDA rejected Orexigen’s proposed new diet drug Contrave, saying the company needed to run another study of its cardiovascular risks. With this rejection, all three of a slate of similar diet drugs from competing pharmaceuticals have been turned back by the agency.

Continue reading FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns

FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns originally appeared on DailyFinance on Tue, 01 Feb 2011 11:17:00.

Filed Under: Company News, Health Care, Stocks in the News

:@aoloriginal, ABT, Arena, ARNA, Company News, contrave, diet, diet drugs, diet pills, fda, FDA advisory panel, FDA approval, food and drug administration, Health Care, lorecaserin, OREX, OREX, VVUS, ARNA, ABT, Orexigen, phen-fen, Qnexa, Stocks in the News, study, Vivus, VVUS

Leave a Reply

You must be logged in to post a comment.

RSS feed for this post (comments) TrackBack URI

You Can Reach Us At:
For All Of Your Towing and Recovery Needs.
Tele: (847) 587-6076
Fax: (847) 587-8610
Search
Some Of Our Pics
Navigation
Recent Posts

Categories
- Towing

Recent Comments

Looking for something?

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!

Blogroll

A few highly recommended websites...

Archives

All entries, chronologically...